BlackRock HealthBME.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, BlackRock Health (BME.N) trades at a P/E of N/A, P/B of 0.99x, P/S of N/A, and a dividend yield of 7.14%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B sits at the 60th percentile over the trailing 10Y window (vs. 83rd percentile over 3Y); P/S historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data).
Cross-sectional valuation: its P/B ranks at the 92nd percentile within its industry and the 29th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 7.14%, ranking at the 49th percentile over the trailing 20Y window.
Relative to the broader market, its P/B shows a deeper discount than it does against industry peers. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. BlackRock Health operates in the other sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: BME · BME
Want the full picture on whether BlackRock Health (BME.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | N/A | — | — | — | — | — | — |
| P/B (MRQ) | 0.99 | ||||||
| P/S (TTM) | N/A | — | — | — | — | — | — |
| Dividend Yield | 7.14% | ||||||
| Buyback + Div Yield | 7.14% |